Diagnostic utility of pediatric epilepsy monitoring unit: Retrospective single center study

Raidah Al-Bradie1, Jumanah A Jarad1, Aziza R Bokhari1

  • 1From the Department of Pediatric Neurology (Al-Bradie, Jarad, Bokhari, Maddallah, Hedaithy, Alqutub, Turkistani), Neuroscience Center (Bashir), King Fahad specialist hospital Dammam, Dammam, Kingdom of Saudi Arabia.

Insights

Epilepsy Monitoring Unit (EMU) admissions are crucial for diagnosing drug-resistant epilepsy (DRE) in children. This study found that EMU evaluations lead to definitive diagnoses in most pediatric epilepsy cases, guiding effective management.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Drug-resistant epilepsy (DRE) presents challenges in pediatric patients despite standard antiepileptic drug (AED) use.
  • Accurate diagnosis is essential for effective management and treatment strategies.

Purpose of the Study:

  • To evaluate the diagnostic utility of Epilepsy Monitoring Unit (EMU) admissions for pediatric patients with drug-resistant epilepsy.
  • To assess the rate of definitive diagnoses achieved through EMU evaluations.

Main Methods:

  • Observational retrospective study of 323 pediatric patients admitted to an EMU between 2012 and 2020.
  • Data collected included patient demographics, referral reasons, seizure frequency, and diagnostic outcomes.

Main Results:

  • The study included 168 males (52.01%).
  • Common referral reasons were characterization (28.17%) and pre-surgical evaluation (17.3%).
  • A definitive diagnosis was established in 75.5% of admissions.

Conclusions:

  • EMU admission is vital for early and accurate diagnosis in pediatric epilepsy patients.
  • EMU evaluations facilitate appropriate management, including surgical considerations for DRE patients.
Abstract

Related Concept Videos